ACCSAP, CathSAP, EP SAP, and HF SAP will be unavailable Jan. 28 - Feb. 2.

Driving Innovation to Transform Cardiovascular Health

The Innovation Program aims to promote and support technologies that help members advance patient care. By connecting clinicians, researchers and industry, the ACC fosters innovation that delivers useful tools and greater member value.

Explore the Program
Fred Masoudi, MD, MACC Fred Masoudi, MD, MACC Chair
Message from the Chair

Program Objectives

The Innovation Program identifies, supports and promotes emerging technologies that empower ACC members to deliver better cardiovascular care.

  • Digital Transformation Advancing technology-enabled solutions to improve cardiovascular care delivery.
  • Practical Resources Delivering workbooks, reports and guidance that support technology adoption in practice.
  • Collaborative Innovation Partnering with industry, academia and others to accelerate impactful tools and solutions.
  • Clinical Expertise Leveraging ACC member insights to guide meaningful, evidence-informed innovation.
  • Patient-Centered Focus Ensuring innovations reflect patient needs and improve outcomes.
  • Learn More About the Innovation Program

Initiatives

AI Resource Center
Featured

AI Resource Center

Discover a collection of AI resources has been curated to support ACC members in understanding and applying AI in the digital transformation of care delivery.

Explore AI Resources
Workbooks and Tools

Workbooks and Tools

Access workbooks and practical tools designed to help clinicians implement and advance remote patient management, telehealth, point-of-care ultrasound, wearable technologies, artificial intelligence (AI) and more.

View Tools

Be Part of Cardiovascular Innovation

Join the Health Care Innovation Member Section to collaborate with peers and help shape the future of cardiovascular care.

Join Today

Innovation Collaborators

  • Aidoc
  • Anumana
  • Butterfly
  • CARTA
  • Cleerly
  • Cliexa
  • Commure
  • CES Consumer Technology Association
  • DME
  • Dispatch Health
  • GE Healthcare
  • HEALTHCARE INNOVATION LAB
  • Heartbeat Health
  • HeartHero
  • Higi
  • Hims
  • Hugo
  • J&J
  • Lupin Digital Health
  • Myia
  • OpenEvidence
  • Osso VR
  • Serv Medical
  • Yale Core

The ACC Foundation's investment portfolio includes investments in the following companies: Myia, cliexa, AngelMD, Abridge, Heart Hero, Heartbeat Health, Carta, Butterfly, Cleerly, Dispatch, and Commure. These investments do not constitute a guarantee or endorsement by the ACC or the ACC Foundation of a specific product, service or therapy offered by these companies.

Start Your AI Journey

Access resources and practical AI guidance tailored to help clinicians make confident, informed decisions in a rapidly evolving landscape.

View AI Resources